Get started
Krka, d. d., Novo mestoKrka, d. d., Novo mestoKrka, d. d., Novo mesto

Krka, d. d., Novo mesto

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasMindsForecasts

Live chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.57 B‬ EUR
Dividend yield (indicated)
4.00%
Price to earnings Ratio (TTM)
17
Basic EPS (TTM)
12 EUR
Net income (FY)
‪356.99 M‬ EUR
Revenue (FY)
‪1.91 B‬ EUR
Shares float
‪20.30 M‬
Beta (1Y)
0.80

Employees


Employees (FY)
‪12.81 K‬
Change (1Y)
‪+1.03 K‬ +8.74%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Krka, d. d., Novo mesto


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jože Colaric
Website
krka.biz
Headquarters
Novo Mesto
Founded
1954
ISIN
SI0031102120
FIGI
BBG019TWNG88
KRKA dd is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of human and animal health products. It operates through the following geographical segments: European Union, South-Eastern Europe, Eastern Europe, and Other. The European Union segment includes all countries of the European Union. The South-Eastern Europe segment consists of Serbia, Bosnia and Herzegovina, Macedonia, Montenegro, Kosovo, and Albania. The Eastern Europe segment comprises of the Russian Federation and other former Soviet Union countries, excluding the Baltic countries. The company was founded by Boris Andrijanic in 1954 and is headquartered in Novo Mesto, Slovenia.

Check out other big names from the same industry as KN8.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Krka, d. d., Novo mesto stocks are traded under the ticker KN8.
We've gathered analysts' opinions on Krka, d. d., Novo mesto future price: according to them, KN8 price has a max estimate of 222.60 EUR and a min estimate of 115.00 EUR. Watch KN8 chart and read a more detailed Krka, d. d., Novo mesto stock forecast: see what analysts think of Krka, d. d., Novo mesto and suggest that you do with its stocks.
KN8 reached its all-time high on Sep 12, 2025 with the price of 224 EUR, and its all-time low was 160 EUR and was reached on Apr 9, 2025. View more price dynamics on KN8 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Krka, d. d., Novo mesto financials in yearly and quarterly reports right on TradingView.
Krka, d. d., Novo mesto is going to release the next earnings report on Nov 13, 2025. Keep track of upcoming events with our Earnings Calendar.
Krka, d. d., Novo mesto revenue for the last quarter amounts to ‪526.20 M‬ EUR, despite the estimated figure of ‪521.75 M‬ EUR. In the next quarter, revenue is expected to reach ‪473.10 M‬ EUR.
KN8 net income for the last quarter is ‪93.67 M‬ EUR, while the quarter before that showed ‪152.18 M‬ EUR of net income which accounts for −38.45% change. Track more Krka, d. d., Novo mesto financial stats to get the full picture.
Yes, KN8 dividends are paid annually. The last dividend per share was 8.25 EUR. As of today, Dividend Yield (TTM)% is 4.00%. Tracking Krka, d. d., Novo mesto dividends might help you take more informed decisions.
Krka, d. d., Novo mesto dividend yield was 5.94% in 2024, and payout ratio reached 71.14%. The year before the numbers were 6.82% and 73.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 24, 2025, the company has ‪12.81 K‬ employees. See our rating of the largest employees — is Krka, d. d., Novo mesto on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Krka, d. d., Novo mesto EBITDA is ‪531.63 M‬ EUR, and current EBITDA margin is 26.90%. See more stats in Krka, d. d., Novo mesto financial statements.
Like other stocks, KN8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Krka, d. d., Novo mesto stock right from TradingView charts — choose your broker and connect to your account.